Technology | 2022.03.09
January Therapeutics Appoints Biotechnology Veteran Thomas Broudy CEO
January Therapeutics, a leading biotechnology company developing targeted medicines for cancer, announced today the appointment of Thomas B. Broudy, PhD, as Chief Executive Officer. Broudy will lead the company’s strategic direction and hold responsibility for advancing the company’s therapeutic programs to their upcoming milestones—including internal development and external partnerships.
(PRWeb March 09, 2022)
Read the full story at https://www.prweb.com/releases/2022/3/prweb18537006.htm
For more information, please visit
https://www.prweb.com/releases/2022/3/prweb18537006.htm
